Completed
Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes
NCT01226966
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Paris La Défense Cedex, France